Connect with us

News

Avalyn Pharma Reports Update in Ongoing Idiopathic Pulmonary Fibrosis Trial

gbafNews28

Avalyn Pharma Inc., a biopharmaceutical company focused on development of improved therapies for life threatening pulmonary diseases, today announced completion of last patient in the initial 24 week evaluation of a Phase I/II clinical study of two dose regimens of AP01 (a formulation of pirfenidone optimized for delivery via inhalation) in patients with idiopathic pulmonary fibrosis (IPF). Ninety-one patients with IPF were randomized to 50 mg once daily (n=46) or 100 mg twice daily (n=45), administered by a PARI investigational eFlow nebulizer. During the first 24 weeks, the high dose group had a trend toward stabilization of lung function as measured by forced vital capacity (FVC). The low dose group had a progressive loss of lung function. Based on these results the data safety monitoring board recommended conversion of all low dose patients to the high dose during the optional 12 month extension which is ongoing. AP01 was safe and well tolerated at both doses. Flu-like symptoms and GI adverse events most commonly attributed to oral pirfenidone were seen in less than 10% of patients treated with AP01. Adverse events with a frequency of greater that 10% were rash 18%, upper respiratory tract infection 18%, cough 24%.

Most subjects have opted to continue in the 12 month extension. Twenty-four week efficacy and safety data will be presented at an upcoming scientific meeting.

We are pleased by the efficacy and safety profile we have seen to date with aerosolized pirfenidone in 91 patients over 24 weeks. The six month FVC data of the high dose is very promising as well as the overall safety profile to date, said Dr. A. Bruce Montgomery, CEO of Avalyn Pharma. “Despite the 2014 approval of two oral antifibrotic therapies, IPF and other fibrotic lung diseases remain fatal diseases with substantial unmet need. We hope to establish improved tolerability and long term efficacy with aerosolized pirfenidone in Phase 3 trials to be initiated in 2021.

Clinical Need

IPF and other fibrotic lung diseases are characterized by progressive scarring, reduced exercise capacity and ultimate death from respiratory failure and/or co-morbidities. IPF treatments are relatively new, with the first and only approvals coming in 2014: oral pirfenidone (Esbriet) and oral nintedanib (Ofev). Both medicines, while effective in slowing disease progression are associated with significant adverse effects that limit dosing and their full potential for efficacy. While these medicines are an important first step to treat IPF, a substantial unmet need remains for therapies with improved safety profiles and better efficacy as either stand-alone or add-on combination therapies in both IPF and other fibrotic lung diseases.

The Inhaled Advantage

Although oral pirfenidone has shown to slow IPF disease progression, it is a low potency drug requiring a very large oral dose to achieve efficacious lung levels. Unfortunately, oral delivery results in blood levels which cause substantial adverse effects and limit the delivered lung dose. In a Phase I single dose study of AP01, we have demonstrated the potential of aerosolized pirfenidone to improve both efficacy and safety. Inhalation of a dose of AP01 equivalent to 1/16 of the licensed oral dose delivered 35-fold higher peak lung levels of pirfenidone.

About Avalyn Pharma

More information can be found at www.Avalynpharma.com.

A. Bruce Montgomery, M.D.

CEO Phone: 1-206-707-0340

Seattle office address

701 Pike Street, Suite 1500

Seattle, WA, 98101

News

Sinic Holdings Assigned ‘BB-‘ with a Positive Outlook by Lianhe Global

gbafNews28

HONG KONG, Oct. 23, 2020 /PRNewswire/ — Sinic Holdings (Group) Company Limited ("Sinic Holdings" or the "Company", together with its subsidiaries, the "Group", stock code: 2103.HK) announces that Lianhe Ratings Global Limited ("Lianhe Global") has assigned the Company a global scale Long-term Issuer Credit Rating of ‘BB-‘ with a Positive Outlook.

Lianhe Global believed that Sinic’s management expects to further grow its scale by deepening the city coverage and expanding into new regions through the twelve regional offices/teams. Sinic uses cash received from its project development to partly fund the growth plan of its market franchise into the provincial cities in the Yangtze River Delta, Greater Bay Area, and Central and West China Region of higher potential. Sinic managed the average time required before presale for high-turnover projects down to about six months in 2019 from approximately eight months in 2018. The change sheds light on the results of its internal benchmarks and indicators that Sinic employed to monitor the status of each development phase.

The Shanghai headquartered developer redesigned the product type by series and modularized its development approach to shorten the average construction duration, which lowered the operating costs and paved the way for its ambitious expansion. More than 90% of Sinic’s high-turnover projects under development at end-2019 were on the new standardized model, somewhat expediting the completion of certain projects.

Lianhe Global expected Sinic to moderately improve its tight liquidity profile with various funding sources – including bank loans, trust loans, bond offerings, and other financing tools such as ABS products, etc. – to fund its expansion blueprint. Sinic is able to tap the onshore fixed-income market. Listed on the Hong Kong Stock Exchange since November 2019, the Company has gained access to the offshore capital market, which further diversified its funding source.

The Chairman and Executive Director of Sinic Holdings, Mr. Zhang Yuanlin said, "The ‘BB-‘ Rating with a Positive Outlook assigned by Lianhe Global is evidence of our long-term investment value, and highlights the recognition of the rating agency of the Company’s performance, stable financial position and high-quality development model. It will also be conducive to the financing of Sinic Holdings in the capital market at a lower cost in the future. Looking forward, in terms of sales, we will adopt a more active and agile product sales and pricing strategy in response to the market change. In terms of operations, we will adjust the delivery cycle in a timely manner according to market demand. In terms of finance, we will carry out a more prudent financial policy and strengthen cash flow management with an aim of securing steady development with a healthy financial condition. Sinic Holdings will consolidate its current market position and further accelerate development of its business, striving to achieve the strategic development of ‘laying a solid foothold in Jiangxi for nationwide development."

About Sinic Holdings (Group) Company Limited

Sinic Holdings (Group) Company Limited is a large-scale and comprehensive property developer in the PRC, focusing on the development of residential and commercial properties. Through over 10 years of operations, the Company has successfully established a leading position among residential property developers in Jiangxi Province and expanded its property development business into the Yangtze River Delta Region, the Greater Bay Region and the Central and Western China Core Cities and other regions with high-growth potential. According to the rankings of CRIC, China Index Academy and EH Consulting, the Company ranked 36th, 32nd, and 31st in terms of sales amount (including all income) among real estate development enterprises of China in 2019. The Company was recognized as one of the China’s Top 50 Real Estate Developers jointly by the China Real Estate Industry Association, Shanghai Yiju Real Estate Research Institution and China Real Estate Appraisal in 2018 and 2019, and one of the China’s Top 30 Real Estate Developers in 2020 and Growth Top 10 in 2020 by the China Real Estate Top 10 Research Committee and China Index Academy in 2020.

The Company residential properties can be categorized into three major series, namely, the "Wan" Series, the "Yuan" Series and the "Yue" Series, which target first-time home purchasers, home upgraders and extended families or high-income households, respectively. As of June 30, 2020, the total land bank attributable to the Company amounted to approximately 15.3 million sq.m., and the Company had 138 projects at various stages of development.

Continue Reading

News

Laiye and RAAS PAL Form Partnership to Drive the Industry-wide Automation

gbafNews28

BANGKOK, Oct. 23, 2020 /PRNewswire/ — Laiye, the leading Robotic Process Automation (RPA) platform provider in Asia, and RAAS PAL, a robotics and AIoT solution provider in Thailand, announced the partnership to provide the industry-wide high-quality automation services in Thailand.

Laiye initially delivered some significant projects including Automated Human Resources Outsourcing (HRO) and built the Virtual Office to drive brand engagement and boost RAAS PAL’s productivity.

Technology is completely changing the way we work. In the newly completed projects, Laiye not only automated parts of RAAS PAL’s online recruitment processes but also delivered a virtual office solution that includes many robot employees performing different tasks, like Human Resources Outsourcing, Financial Services Outsourcing, etc. Laiye aims to drive the promise of the fully automated enterprise for the most strategic companies.

"This first step in the adoption of RPA in our group processes has been extremely meaningful for us. We particularly liked the fact that we could start from small to scale. Besides the short learning curve, what touches us even more was Laiye UiBot’s services," said CEO of RAAS PAL. 

This cooperation is expected to deliver automation value to clients of all industries, with those in regulated industries such as finance, banking, manufacturing, human resource, healthcare and more. Furthermore, entrepreneurs see a lot of potential in automating the processes which bring innovative benefits to various aspects of enterprise business.

About Laiye

Founded in 2015, Laiye is a forward-looking company focused on offering automation solutions to a wide range of users from individuals to enterprises. Laiye is a pioneering company in Robotic Process Automation (RPA) and artificial intelligence with more than 19-year experience. Laiye’s mission is to automate all rule-based, repetitive, high-volume digital tasks for you and your business to increase creativity and productivity.

Additional Resources
Follow Laiye on LinkedIn, Facebook, and Twitter, or contact the team at [email protected].

 

Continue Reading

News

Amcor to report First Quarter 2021 Results

gbafNews28

ZURICH, Switzerland, Oct. 23, 2020 /PRNewswire/ — Amcor plc (NYSE: AMCR; ASX: AMC) will announce its First Quarter 2021 results for the three months ended 30 September 2020 after the US market closes on Thursday 5 November 2020.  

A conference call and webcast to discuss the results will be held at 5.00 pm US Eastern Standard Time on Thursday 5 November 2020 / 9.00 am Australian Eastern Daylight Time on Friday 6 November 2020. For those wishing to participate in the call please use the following dial-in numbers:

US and Canada:

866 211 4133 (toll-free)

Australia:  

1800 287 011 (toll-free)

United Kingdom:

0800 051 7107 (toll-free)

Hong Kong: 

800 901 563 (toll-free)

Singapore:

800 852 6506 (toll-free)

All other countries:

+1 647 689 6614 (this is not a toll-free number)

Conference ID

3965578

Access to the webcast and supporting materials will be available via the Investors section of Amcor’s website (www.amcor.com/investors). A webcast replay will be available at the conclusion of the call.  

In line with Amcor’s reporting obligations, a Quarterly Report on Form 10-Q will be filed with the SEC by Monday 9 November 2020.

ENDS

For further information please contact:

Investors:

Tracey Whitehead

Damien Bird

Head of Investor Relations

Vice President Investor Relations

Amcor

Amcor

+61 3 9226 9028

+61 3 9226 9070

[email protected]

[email protected]  

Media – Europe

Media – Australia

Media – North America

Ernesto Duran

James Strong

Daniel Yunger

Head of Global Communications

Amcor

Citadel-MAGNUS

KekstCNC

+41 78 698 69 40

+61 448 881 174

+1 212 521 4879

[email protected]

[email protected]

[email protected]

 

About Amcor
Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products.  Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve value chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using a rising amount of recycled content. Around 47,000 Amcor people generate US$12.5 billion in sales from operations that span about 230 locations in 40-plus countries.  NYSE: AMCR; ASX: AMC

www.amcor.com  I  LinkedIn  I  Facebook  I  Twitter  I  YouTube

Related Links :

http://www.amcor.com

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News23 mins ago

Amcor to report First Quarter 2021 Results

ZURICH, Switzerland, Oct. 23, 2020 /PRNewswire/ — Amcor plc (NYSE: AMCR; ASX: AMC) will announce its First Quarter 2021 results...

gbafNews28 gbafNews28
News23 mins ago

Laiye and RAAS PAL Form Partnership to Drive the Industry-wide Automation

BANGKOK, Oct. 23, 2020 /PRNewswire/ — Laiye, the leading Robotic Process Automation (RPA) platform provider in Asia, and RAAS PAL, a...

gbafNews28 gbafNews28
News23 mins ago

Sinic Holdings Assigned ‘BB-‘ with a Positive Outlook by Lianhe Global

HONG KONG, Oct. 23, 2020 /PRNewswire/ — Sinic Holdings (Group) Company Limited ("Sinic Holdings" or the "Company", together with its...

gbafNews28 gbafNews28
News32 mins ago

EML Payments (EML): Storing up value

LONDON, UK – EQS Newswire – 23 October 2020 – EML Payments is a specialist payment solutions provider with a focus...

gbafNews28 gbafNews28
News32 mins ago

Recreate Cinematic Experiences with Samsung’s Latest Displays and Soundbars, Right In Your Living Room

Engage your senses for an immersive theatrical experience in the comfort of your home   SINGAPORE – Media OutReach – 23 October...

gbafNews28 gbafNews28
News2 hours ago

Global Event Management Software Market | Rising Adoption of Real-time Management Systems to Boost the Market Growth | Technavio

The global event management software market size is poised to grow by USD 3.28 billion during 2020-2024, progressing at a...

gbafNews28 gbafNews28
News2 hours ago

ACT, Inc., Panish Shea & Boyle LLP, and Miller Advocacy Group PC Comment on Court’s Preliminary Approval of $16 Million Settlement in Class Action Lawsuit Against ACT for Alleged Violations Related to Certain Students with Disabilities

ACT, Inc., Panish Shea & Boyle LLP, and Miller Advocacy Group PC today release the following joint statement: A settlement...

gbafNews28 gbafNews28
News2 hours ago

Global Application Lifecycle Management Market|Demand for SaaS-based ALM to Boost the Market Growth | Technavio

The global application lifecycle management market size is poised to grow by USD 1.78 billion during 2020-2024, progressing at a...

gbafNews28 gbafNews28
News2 hours ago

Acies Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

Acies Acquisition Corp. (NASDAQ: ACACU, the “Company”) announced today that it priced its initial public offering of 20,000,000 units at...

gbafNews28 gbafNews28
News2 hours ago

Laboratory Information Management System (LIMS) Market | Growing Demand For Bio-banking to Boost the Market Growth | Technavio

The global laboratory information management system (LIMS) market size is poised to grow by USD 705.85 million during 2020-2024, progressing...